Nabla Bio, Inc.

About Nabla Bio, Inc.

Nabla Bio is a biotechnology company developing AI-driven protein design tools to accelerate drug discovery. The company combines deep learning, computational biophysics, and high-throughput experimentation to engineer antibodies and other therapeutic proteins with improved specificity, stability, and developability. Nabla's platform predicts protein structure, interactions, and mutations to reduce the time and cost required to reach clinical candidates. The company partners with pharmaceutical and biotech firms to co-develop drug candidates across oncology, immunology, and rare diseases, leveraging its generative models to expand the therapeutic potential of engineered proteins.